Home » Stocks » Aethlon Medical

Aethlon Medical, Inc. (AEMD)

Stock Price: $1.53 USD -0.02 (-1.29%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $1.55 +0.02 (1.31%) Oct 21, 5:36 PM

Stock Price Chart

Key Info

Market Cap 18.47M
Revenue (ttm) 620,187
Net Income (ttm) -5.72M
Shares Out 12.07M
EPS (ttm) -1.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $1.53
Previous Close $1.55
Change ($) -0.02
Change (%) -1.29%
Day's Open 1.55
Day's Range 1.51 - 1.60
Day's Volume 171,033
52-Week Range 0.76 - 5.02

More Stats

Market Cap 18.47M
Enterprise Value 2.75M
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 12.07M
Float 11.72M
EPS (basic) -1.07
EPS (diluted) -1.04
FCF / Share -0.54
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 408,508
Short Ratio 1.95
Short % of Float 3.49%
Beta 0.35
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 29.78
PB Ratio 1.25
Revenue 620,187
Operating Income -5.77M
Net Income -5.72M
Free Cash Flow -5.22M
Net Cash 15.72M
Net Cash / Share 1.30
Gross Margin 104.84%
Operating Margin -931.04%
Profit Margin -921.90%
FCF Margin -841.76%
ROA -37.28%
ROE -70.64%
ROIC 1,323.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$9.00*
Low
9.00
Current: $1.53
High
9.00
Target: 9.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.650.230.150.390.890.761.621.231.36-
Revenue Growth183.15%53.47%-61.84%-55.78%16.28%-53.05%32.01%-9.53%--
Gross Profit0.650.230.150.390.890.761.621.231.36-
Operating Income-5.93-6.00-4.83-6.10-4.38-3.99-3.06-3.58-3.11-4.56
Net Income-6.37-6.19-5.68-7.28-4.87-6.80-13.36-4.89-8.11-5.71
Shares Outstanding3.411.210.820.520.490.370.260.200.140.09
Earnings Per Share-1.87-5.13-6.90-14.10-9.90-18.30-51.60-22.50-60.00-60.00
Operating Cash Flow-5.20-4.29-3.91-3.51-4.33-5.05-2.14-2.10-1.84-1.97
Capital Expenditures-0.15--0.02-0.02-0.01--0.10---
Free Cash Flow-5.35-4.29-3.94-3.52-4.34-5.05-2.24-2.10-1.84-1.97
Cash & Equivalents9.623.846.991.572.150.861.250.130.150.22
Total Debt0.040.960.840.520.500.162.532.693.662.37
Net Cash / Debt9.572.886.151.061.650.70-1.28-2.56-3.51-2.15
Assets10.394.127.351.732.531.381.700.500.840.57
Liabilities1.111.821.321.131.030.7316.439.6410.136.54
Book Value9.412.436.130.681.550.62-14.95-9.14-9.30-5.98
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aethlon Medical, Inc.
Country United States
Employees 8
CEO Timothy C. Rodell

Stock Information

Ticker Symbol AEMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AEMD

Description

Aethlon Medical, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.